{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T12:09:21Z","timestamp":1761394161905,"version":"3.40.2"},"reference-count":28,"publisher":"Pharmaceutical Society of Japan","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2012]]},"DOI":"10.1248\/bpb.35.487","type":"journal-article","created":{"date-parts":[[2012,4,2]],"date-time":"2012-04-02T04:19:28Z","timestamp":1333340368000},"page":"487-493","source":"Crossref","is-referenced-by-count":27,"title":["Influence of Concomitant Antiepileptic Drugs on Plasma Lamotrigine Concentration in Adult Japanese Epilepsy Patients"],"prefix":"10.1248","volume":"35","author":[{"given":"Yoshiaki","family":"Yamamoto","sequence":"first","affiliation":[{"name":"Department of Clinical Research, National Epilepsy Center, Shizuoka Institute of Epilepsy and Neurological Disorders"},{"name":"Department of Clinical Pharmaceutics, Graduate School of Pharmaceutical Sciences University of Shizuoka"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yushi","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Clinical Research, National Epilepsy Center, Shizuoka Institute of Epilepsy and Neurological Disorders"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumi","family":"Matsuda","sequence":"additional","affiliation":[{"name":"Department of Clinical Research, National Epilepsy Center, Shizuoka Institute of Epilepsy and Neurological Disorders"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukitoshi","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Clinical Research, National Epilepsy Center, Shizuoka Institute of Epilepsy and Neurological Disorders"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Kagawa","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmaceutics, Graduate School of Pharmaceutical Sciences University of Shizuoka"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1996.tb00605.x"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-199706000-00002"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Chong E, Dupuis LL. Therapeutic drug monitoring of lamotrigine. <i>Ann. Pharmacother.<\/i>, <b>36<\/b>, 917&#8211;920 (2002).","DOI":"10.1345\/1542-6270(2002)036<0917:TDMOL>2.0.CO;2"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200645110-00002"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Hirsch LJ, Weintraub D, Du Y, Buchsbaum R, Spencer HT, Hager M, Straka T, Bazil CW, Adams DJ, Resor SR Jr, Morrell MJ. Correlating lamotrigine serum concentrations with tolerability in patients with epilepsy. <i>Neurology<\/i>, <b>63<\/b>, 1022&#8211;1026 (2004).","DOI":"10.1212\/01.WNL.0000138424.33979.0C"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1998.00835.x"},{"issue":"3","key":"7","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/S0022-3565(25)11424-9","volume":"260","year":"1992","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3565","issn-type":"print"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Rowland A, Elliot DJ, Williams JA, Mackenzie PI, Dickinson RG, Miners JO. <i>In vitro<\/i> characterization of lamotrigine <i>N<\/i>2-glucuronidation and the lamotrigine-valproic acid interaction. <i>Drug Metab. Dispos.<\/i>, <b>34<\/b>, 1055&#8211;1062 (2006).","DOI":"10.1124\/dmd.106.009340"},{"issue":"1","key":"9","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1365-2125.1989.tb03514.x","volume":"28","year":"1989","ISSN":"https:\/\/id.crossref.org\/issn\/0306-5251","issn-type":"print"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-199610000-00001"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1177\/00912709922007949"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-199904000-00008"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Gidal BE, Anderson GD, Rutecki PR, Shaw R, Lanning A. Lack of an effect of valproate concentration on lamotrigine pharmacokinetics in developmentally disabled patients with epilepsy. <i>Epilepsy Res.<\/i>, <b>42<\/b>, 23&#8211;31 (2000).","DOI":"10.1016\/S0920-1211(00)00160-1"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Rivas N, Buelga DS, Elger CE, Santos-Borbujo J, Otero MJ, Dom&iacute;nguez-Gil A, Garc&iacute;a MJ. Population pharmacokinetics of lamotrigine with data from therapeutic drug monitoring in German and Spanish patients with epilepsy. <i>Ther. Drug Monit.<\/i>, <b>30<\/b>, 483&#8211;489 (2008).","DOI":"10.1097\/FTD.0b013e31817fd4d4"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Lalic M, Cvejic J, Popovic J, Bozic K, Golocorbin-Kon S, Al-Salami H, Mikov M. Lamotrigine and valproate pharmacokinetics interactions in epileptic patients. <i>Eur. J. Drug Metab. Pharmacokinet.<\/i>, <b>34<\/b>, 93&#8211;99 (2009).","DOI":"10.1007\/BF03191157"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-199712000-00003"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1997.00594.x"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2011.01.016"},{"issue":"2","key":"19","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/FTD.0b013e3181ceecc6","volume":"32","author":"SANCHEZ MARIA BLANCA","year":"2010","ISSN":"https:\/\/id.crossref.org\/issn\/0163-4356","issn-type":"print"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20131"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.2133\/dmpk.20.144"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Saeki M, Saito Y, Jinno H, Tanaka-Kagawa T, Ohno A, Ozawa S, Ueno K, Kamakura S, Kamatani N, Komamura K, Kitakaze M, Sawada J. Single nucleotide polymorphisms and haplotype frequencies of UGT2B4 and UGT2B7 in a Japanese population. <i>Drug Metab. Dispos.<\/i>, <b>32<\/b>, 1048&#8211;1054 (2004).","DOI":"10.1016\/S0090-9556(24)02990-8"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2006.01.002"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-200011000-00002"},{"key":"25","unstructured":"25) Lampe JW, Bigler J, Bush AC, Potter JD. Prevalence of polymorphisms in the human UDP-glucuronosyltransferase 2B family: UGT2B4(D458E), UGT2B7(H268Y), and UGT2B15(D85Y). <i>Cancer Epidemiol. Biomarkers Prev.<\/i>, <b>9<\/b>, 329&#8211;333 (2000)."},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Chung JY, Cho JY, Yu KS, Kim JR, Lim KS, Sohn DR, Shin SG, Jang IJ. Pharmacokinetic and pharmacodynamic interaction of lorazepam and valproic acid in relation to UGT2B7 genetic polymorphism in healthy subjects. <i>Clin. Pharmacol. Ther.<\/i>, <b>83<\/b>, 595&#8211;600 (2008).","DOI":"10.1038\/sj.clpt.6100324"},{"key":"27","unstructured":"27) Gidal BE, Sheth R, Parnell J, Maloney K, Sale M. Evaluation of VPA dose and concentration effects on lamotrigine pharmacokinetics: implications for conversion to lamotrigine monotherapy. <i>Epilepsy Res.<\/i>, <b>57<\/b>, 85&#8211;93 (2003)."},{"key":"28","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-081X(199907)20:5<233::AID-BDD179>3.3.CO;2-X"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/35\/4\/35_4_487\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T20:06:57Z","timestamp":1742846817000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/35\/4\/35_4_487\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.35.487","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"type":"print","value":"0918-6158"},{"type":"electronic","value":"1347-5215"}],"subject":[],"published":{"date-parts":[[2012]]}}}